September 1, 2022 – Update by the federal government regarding the COVID-19 pandemic
Here is a status report on the recent decisions and actions of the federal government in relation to the COVID-19 pandemic.
Jean-Yves Duclos, Minister of Health, reports on the COVID-19 situation in Canada.
New bivalent vaccine
Canadian Public Health has approved Moderna’s bivalent COVID-19 vaccine.
This new vaccine targets both the original strain of COVID-19 and the Omicron BA subvariant. 1.
“Each dose of Moderna’s new bivalent vaccine contains 50 mg of messenger RNA, with 25 mg targeting the original strain of SARS-COV-2, and 25 mg specifically targeting the Omicron subvariant. It’s essentially two vaccines in one,”, says Dr. Marc Berthiaume.
The National Advisory Committee on Immunization (NACI) recommends that a dose of bivalent vaccine be offered for adolescents who are immunosuppressed or who have risk factors that put them at high risk, as well as for adults.
Note that the studies carried out to date do not show any differences between the two vaccines concerning the side effects, which go away quickly.
A total of 780,000 doses of the vaccine will arrive in Canada on September 2, 2022, and will be distributed to provinces and territories.
The vaccination campaign should start in the next few weeks.